ORLYNVAH Trademark

Trademark Overview

On Monday, August 12, 2024, a trademark application was filed for ORLYNVAH with the United States Patent and Trademark Office. The USPTO has given the ORLYNVAH trademark a serial number of 98693845. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 3, 2025. This trademark is owned by Iterum Therapeutics International Limited. The ORLYNVAH trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely antibiotics
orlynvah

General Information

Serial Number98693845
Word MarkORLYNVAH
Filing DateMonday, August 12, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, June 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 8, 2025

Trademark Statements

Goods and Servicespharmaceutical preparations, namely antibiotics
Translation of Words in MarkThe wording ORLYNVAH has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIterum Therapeutics International Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDublin 1 D01H104
IE
Party NameIterum Therapeutics International Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDublin D01C4E0
IE

Trademark Events

Event DateEvent Description
Monday, August 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 12, 2024NEW APPLICATION ENTERED
Wednesday, November 20, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 4, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 20, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 4, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 4, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 10, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 19, 2025ASSIGNED TO EXAMINER
Thursday, February 20, 2025NON-FINAL ACTION E-MAILED
Thursday, February 20, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 20, 2025NON-FINAL ACTION WRITTEN
Monday, March 10, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 11, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 12, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 8, 2025PUBLISHED FOR OPPOSITION
Wednesday, April 2, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 8, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 5, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 5, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 5, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 3, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

orlynvah antibiotics namely preparations pharmaceutical